Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) saw a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 3,900 shares, ...

32.0% of VanEck Biotech ETF shares are owned by institutional investors. 6.1% of Mexico Equity & Income Fund shares are owned by insiders. Strong institutional ownership is an indication that ...

The SPDR S&P Biotech ETF (XBI) made its debut on 01/31/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. The ETF industry ...

the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011. While an excellent vehicle for long term investors, passively managed ETFs are a popular choice ...

the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006. Passively managed ETFs are becoming increasingly popular with institutional as well as retail ...

"The reality is, for the biotech industry, while research is the ... and leaders across sectors and in the ETF space. For more expert insight and the latest market action, click here&nbsp ...

Biotech stocks are oversold. This near-term bottom might be the start of a long-term bull run. IBB and XBI offer different advantages. IBB can benefit from the flight to safety trade. XBI provides ...

Major industry benchmarks SPDR S&P Biotech ETF (NYSEARCA:XBI) and the iShares Biotechnology ETF (NASDAQ:IBB) have both trailed the S&P 500 (SP500) over the past 12 months. Operating in an industry ...

The Fund seeks to track the investment results of the Dynamic Biotech & Genome Intellidex. The Fund generally will invest at least 90% of its total assets in common stocks of biotechnology ...